700 UK arthritis patients to reveal Real-World drug performance
NCT ID NCT07166315
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 22 times
Summary
This study follows 700 adults with axial spondyloarthritis or psoriatic arthritis who have just started a new medication. Researchers will review medical records and ask patients about their experiences to see how well the treatments control disease activity over 12 months. The goal is to understand real-world effectiveness, not to test a new drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIATIC ARTHRITIS (PSA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Royal National Hospital for Rheumatic Diseases
RECRUITINGBath, Somerset, BA1 3NG, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.